Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico.
about
Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhoodDocosahexaenoic Acid and Cognition throughout the LifespanBenefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactationFishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cellsReview of fortified food and beverage products for pregnant and lactating women and their impact on nutritional statusPrenatal determinants of cord blood total immunoglobulin E levels in Mexican newbornsIndoor determinants of dustborne allergens in Mexican homesAuditory- and visual-evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy.The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial.Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in childrenDHA supplementation and pregnancy outcomes.Fatty acid composition of 12 fish species from the Black Sea.Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in MexicoDocosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women.Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants.Omega-3 fatty acids EPA and DHA: health benefits throughout life.Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial.Breastfeeding status at age 3 months is associated with adiposity and cardiometabolic markers at age 4 years in Mexican children.Prenatal Supplementation with Docosahexaenoic Acid Has No Effect on Growth through 60 Months of AgePlacental insufficiency and fetal growth restrictionPrenatal Docosahexaenoic Acid Supplementation and Offspring Development at 18 Months: Randomized Controlled Trial.Maternal Fatty Acids and Their Association with Birth Outcome: A Prospective Study.Fish oil supplementation improves pregnancy outcomes and size of the newborn: a meta-analysis of 21 randomized controlled trials.Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.The Economic Impact of Lower Protein Infant Formula for the Children of Overweight and Obese Mothers.Maternal single nucleotide polymorphisms in the fatty acid desaturase 1 and 2 coding regions modify the impact of prenatal supplementation with DHA on birth weight.Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study.Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countriesPrenatal DHA supplementation and infant attention.Interactive effects of in utero nutrition and genetic inheritance on cognition: new evidence using sibling comparisons.Prenatal exposure to methylmercury and LCPUFA in relation to birth weight.Validity of a food frequency questionnaire to estimate long-chain polyunsaturated fatty acid intake among Japanese women in early and late pregnancyMaternal fatty acid status during pregnancy and lactation and relation to newborn and infant status.Impact of fatty acid status on growth and neurobehavioural development in humans.Fatty acid status and maternal mental health.Essential fats: how do they affect growth and development of infants and young children in developing countries? A literature review.Omega 3 polyunsaturated fatty acids and body weight.Omega 3 fatty acids, gestation and pregnancy outcomes.Omega 3 fatty acids on child growth, visual acuity and neurodevelopment.
P2860
Q24186353-FA71BBF0-B153-46AA-9E72-296D0D8F4AE4Q26768442-7A4DC299-A723-419C-B52F-E231151AFB18Q26996382-BF7082F1-4648-4756-B17F-B3CB7E54DA31Q26999257-C2660096-32EF-4C16-B46A-440F06FD475CQ27022094-A421DAB4-5A9E-4A9D-AFF5-1E9D7C42CAA3Q28383231-793105B2-847F-47CF-9375-B2B8B28E6C37Q28388430-2D24DB7C-064A-4AF4-A558-0FA530EDAFB4Q30451577-01E60691-535D-42D4-BBC3-0991E30A5D5CQ33566821-9411A3B7-D9C9-41E6-AA98-638DEAB4DE69Q33850028-02CF2FC9-79E6-4240-95AA-31C9C421E7BCQ34004358-1FE356C4-C82B-4D47-A398-C6BB36C4B939Q34035656-8384FAE3-DBAD-4160-8493-B89C14BCC32AQ34230910-535BD1EE-42AB-4F4C-ADDB-42A351415D62Q34493189-FC7784B6-CEA8-4922-A58C-FFDE237999E4Q34493196-63868C17-4CDF-4E48-B6FF-6206F4752BE6Q34627395-5F00F80A-2BAA-467C-9EAE-A87B3AC7DD21Q34635830-B6A208C9-EE83-4536-9890-B38AA1CF0482Q35187388-9E07E155-A480-4B67-AEB6-23553F3B13ABQ35639993-A61836EE-FECB-4431-A8C8-141CE4F0597AQ35640009-07C89A34-2983-494C-80A3-9BD5BA72EC8FQ35670144-BE44BCAB-F446-4358-82EB-63406B774734Q35742542-D7484DC6-9C43-4DC4-AA76-ED6C10B78D7FQ35905570-C7F339FD-B150-487D-B01B-88D43A310DC7Q35969619-D1BD36DD-84CD-415E-B9D1-D12481B6461EQ36279075-911911DD-1DB0-448A-A39E-0D38FA91D00BQ36507429-B61EE15F-9C60-4F71-993B-5C69677EE81AQ36728637-2CEBE8E6-C399-43B9-8E38-BC5D80A8FB69Q37016511-C2C1879B-405F-43A7-8A61-092C9F066A3AQ37276273-F7BEB8D6-A5E8-4BA2-9209-EB57417ABE48Q37511956-906F6E64-32B2-4A9B-A44F-85A74056714AQ37619857-DB6C9E1B-48A9-4F7C-B040-209873DABF8AQ37633309-8F1DAD4B-1B60-4BD7-B124-F4154B8FF55BQ37670164-37DC11CE-8DE2-4C2F-8194-D056E4472C62Q37848935-68E1AA66-5A57-4BAF-9BDD-A55F15D6D64EQ37848937-8A12F470-3EA0-4292-98E2-F5000CAF4386Q37848940-5A496058-EE0F-4E6C-8F31-E9AAAC1E0BB6Q37935090-ED491C75-0515-4CCB-84DB-99C6167E540DQ38010550-651254F4-0797-4EEA-A99F-CE228FAF8156Q38010564-D0D080C1-A73C-4093-942F-95C438552B78Q38010565-CBC38B29-DBC3-4EBB-B468-15D63B41F269
P2860
Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@en
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@nl
type
label
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@en
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@nl
prefLabel
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@en
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@nl
P2093
P2860
P1476
Effects of docosahexaenoic aci ...... bo-controlled trial in Mexico.
@en
P2093
Aryeh D Stein
Beth Imhoff-Kunsch
Juan Rivera
Reynaldo Martorell
Sergio Juárez-Márquez
Socorro Parra-Cabrera
Usha Ramakrishnan
P2860
P304
P356
10.1177/15648265100312S203
P433
P577
2010-06-01T00:00:00Z